Prevalence and Prognostic Significance of Proteinuria in Patients with Lung Cancer

References

• Eagen J W, Lewis E. Glomerulopathies of neoplasia. Kidney Int 1977; 11: 297–306
   PubMed Web of Science ®Google Scholar
• Kaplan B S, Klassen J, Gault M H. Glomerular injury in patients with neoplasia. Annu Rev Med 1976; 27: 117–25
   PubMed Web of Science ®Google Scholar
• Cameron J S, Ogg C S. Neoplastic disease and the nephrotic syndrome. Q J Med 1975; 44: 630–1
   Google Scholar
• Heaton J M, Menzin M A, Carney D N. Extrarenal malignancy and the nephrotic syndrome. J Clin Pathol 1975; 28: 944–6
   PubMedGoogle Scholar
• Jermanovich N B, Giammarco R, Ginsberg S J, Tinsley R W, Jones D B. Small cell anaplastic carcinoma of the lung with mesangial proliferative glomerulonephritis. Arch Intern Med 1982; 142: 397–9
   PubMedGoogle Scholar
• Norris S H. Paraneoplastic glomerulopathies. Semin Nephrol 1993; 13: 258–72
   PubMed Web of Science ®Google Scholar
• Mehmet F F, McKinney T D, Richardson R L, Hande K R, Oldham R K, Greco F A. Cancer and the kidney: Renal complications of neoplasms. Am J Med 1981; 71: 704–18
   PubMedGoogle Scholar
• Sawyer N, Wadsworth J, Wijnen M, Gabriel R. Prevalence, concentration, and prognostic importance of proteinuria in patients with malignancies. Br Med J 1988; 296: 1295–8
   PubMedGoogle Scholar
• Puolijoki H, Mustonen J, Pettersson E, Pasternack A, Lahdensuo A. Proteinuria and haematuria are frequently present in patients with lung cancer. Nephrol Dial Transplant 1989; 4: 947–50
   PubMedGoogle Scholar
• Rudman D, Rio A, Akgum S, Frumin E. Novel proteins and peptides in the urine of patients with advanced neoplastic disease. Am J Med 1969; 46: 174–87
   PubMedGoogle Scholar
• Hemmingsen L, Skaarup P. Urinary excretion of ten plasma proteins in patients with extrarenal epithelial carcinoma. Acta Chir Scand 1977; 143: 177–83
   PubMedGoogle Scholar
• Davison A M, Thomson D. Malignancy-associated glomerular disease. Oxford Textbook of Clinical Nephrology, J S Cameron, A M Davison, J-P Grunfeld, et al. Oxford, New York, NY 1992; 475–86
   Google Scholar
• Kannel W B, Stampfer M J, Castelli W P, Verter J. The prognostic significance of proteinuria: the Framingham study. Am Heart J 1984; 108: 1347–52
   PubMed Web of Science ®Google Scholar
• Histological typing of lung tumours. 2nd. ed. World Health Organization, Geneva 1981
   Google Scholar
• Mountain C F. A new international staging system for lung cancer. Chest 1986; 89: 225–33
   PubMed Web of Science ®Google Scholar
• Kaplan E L, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–81
   Web of Science ®Google Scholar
• Peto R, Pike M C, Armitage R, et al. Design and analysis of clinical trials requiring prolonged observation of each patient. Br J Cancer 1977; 35: 1–47
   PubMed Web of Science ®Google Scholar
• Cox D R. Regression model and life tables. J R Stat Soc (Series B) 1972; 34: 187–220
   Web of Science ®Google Scholar
• Lee J R, Yamauchi H, Hopper J, Jr. The association of cancer and nephrotic syndrome. Ann Intern Med 1966; 64: 41–51
   PubMed Web of Science ®Google Scholar
• Brueggemeyer C D, Ramirez G. Membranous nephropathy: A concern for malignancy. Am J Kidney Dis 1987; 9: 23–6
   PubMed Web of Science ®Google Scholar
• Pascal R R, Iannoccone P M, Rollwagen F M, Harding T A, Bennett S J. Electron microscopy and immunofluorescence of glomerular immune complex deposits in cancer patients. Cancer Res 1976; 36: 43–7
   PubMed Web of Science ®Google Scholar
• Mustonen J, Henn H, Pasternack A. IgA nephropathy associated with bronchial small cell carcinoma. Am J Clin Pathol 1981; 76: 652–6
   PubMedGoogle Scholar
• Savin V J. Mechanisms of proteinuria in noninflammatory glomerular diseases. Am J Kidney Dis 1993; 21: 347–62
   PubMed Web of Science ®Google Scholar
• Rossen R D, Reisberg M A, Singer D, et al. The effect of age on the character of immune complex disease: A comparison of the incidence and relative size of materials reactive with Clq in sera of patients with glomerulonephritis and cancer. Medicine 1979; 58: 65–79
   PubMedGoogle Scholar
• Olson J L, Philips T M, Lewis M G, Solez K. Malignant melanoma with renal dense deposits containing tumour antigens. Clin Nephrol 1979; 12: 74–82
   PubMedGoogle Scholar
• Costanza M E, Pinn V, Schwartz R S, Nathanson L. Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome. N Engl J Med 1973; 289: 520–2
   PubMed Web of Science ®Google Scholar
• Beaufils H, Jouanneau C, Chomette G. Kidney and cancer: results of immunofluorescence microscopy. Nephron 1985; 40: 303–8
   PubMedGoogle Scholar
• Lewis M G, Loughridge L W, Philips T M. Immunological studies in nephrotic syndrome associated with extrarenal malignant disease. Lancet 1971; 2: 134–5
   PubMed Web of Science ®Google Scholar
• Sutherland J C, Markham R V, Mardiney M R. Subclinical immune complexes in the glomeruli of kidneys postmortem. Am J Med 1974; 57: 536–41
   PubMedGoogle Scholar
• Glassock R J, Cohen A H, Adler S G, . Secondary glomerular diseases. The Kidney, B M Brenner, F C Rector, et al. Saunders, Philadelphia, PA 1991; 1280–368
   Google Scholar
• Alpers C E, Cotran R S. Neoplasia and glomerular injury. Kidney Int 1986; 30: 465–73
   PubMed Web of Science ®Google Scholar
• Moorthy A V, Zimmerman S W, Burkholder P M. Nephrotic syndrome in Hodgkin's disease. Evidence for pathogenesis alternative to immune complex deposition. Am J Med 1976; 61: 471–7
   PubMed Web of Science ®Google Scholar
• Shalhoub R J. Pathogenesis of lipoid nephrosis: A disorder of T-cell function. Lancet 1974; 2: 556–9
   PubMed Web of Science ®Google Scholar
• Gluck M C, Gallo G, Lowenstein J, Baldwin D S. Membranous glomerulonephritis. Evaluation of clinical and pathologic features. Ann Intern Med 1973; 78: 1–12
   PubMed Web of Science ®Google Scholar
• Yamauchi H, Linsey M S, Maiava C G, et al. Cure of membranous nephropathy after resection of carcinoma. Arch Intern Med 1985; 145: 2061–3
   PubMedGoogle Scholar
• Froom D W, Franklin W A, Hano J E, Potter E V. Immune deposits in Hodgkin's disease with nephrotic syndrome. Arch Pathol Lab Med 1972; 94: 547–53
   Google Scholar